Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Clover - Caught on Camera

MAGA Nicki Minaj Goes From 'American Idol' to Judging Trump Admin's $1 Million Pitch Competition

Nicki Minaj will judge the SBA's Million Dollar Pitch Competition on 18 September, joining Grant Cardone and Joe Gebbia. Five innovative small businesses will win a share of the $1M prize.

International Business Times UK

Nicki Minaj Joins Pitch Night to Help Split a $1 Million Clover Prize Among Five US Firms

Nicki Minaj joins a celebrity panel for a pitch night, awarding $1 million to five US firms. The event, hosted by Dean Cain, highlights American enterprise.

International Business Times UK

Trump Administration Taps Nicki Minaj and Dean Cain for 'Shark Tank'-Style Pitch Competition

The SBA's Million-Dollar Pitch Competition features Nicki Minaj and Dean Cain, offering $1 million in private funds to small businesses.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Fiserv’s Debit Network Talks Raise a Bigger Question for Visa and Mastercard

Big banks are reportedly weighing a $15 billion bid for Fiserv's STAR debit network to bypass Durbin fee caps, as Visa and Mastercard face settlement costs and stablecoin competition.

MarketBeat

Michael Burry Buys More of This Stock Despite a 71% Collapse and CEO Departure: Here's Why

Michael Burry remains optimistic about Fiserv despite its stock plunge and CEO departure, and purchased the stock again at $48.50 apiece.

International Business Times UK

Fiserv CEO Says AI, Clover Can Help Restore Predictable Growth After Tough Year

Fiserv (NASDAQ:FISV) President and CEO Mike Lyons said the payments and financial technology company is working to restore what he described as its historically predictable, mid-single-digit revenue growth profile after a difficult year for investors. Speaking at a Bernstein-hosted discussion with

MarketBeat

Fiserv Targets ‘Constant Compounder’ Comeback as Clover, AI and Banking Bets Ramp

Fiserv (NASDAQ:FISV) Chief Executive Officer Mike Lyons said the payments and financial technology company is focused on returning to a “constant compounder” profile by sharpening its business mix, improving execution and investing around two major markets: banking and commerce. Speaking with J.P.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Fiserv Investor Day Sets AI, Clover Roadmap to Revive Growth and Top $12 EPS

Fiserv (NASDAQ:FISV) executives used the company’s 2026 Investor Day to outline a medium-term plan aimed at restoring what CEO Mike Lyons described as Fiserv’s historical identity as a “constant compounder,” while acknowledging recent service, product delivery and client retention challenges. Lyons

MarketBeat

Ally Voss, Founder of Clover London, Shares a Glimpse Into Her 9-5

The brains behind the contemporary bridal brand lifts the lid on her stylish world

Marie Claire

How to Select The Best Card Machine for Your Customer Needs

Selecting the right card machine is crucial for businesses aiming to provide seamless payment experiences. With numerous options available, it's essential to understand your specific needs to make an informed choice.

inkl

"The failure of Scalebound was ultimately the responsibility of PlatinumGames, myself as director included"— Hideki Kamiya, creator of Devil May Cry and Okami, takes responsibility for Scalebound's cancellation

VGA recently interviewed Hideki Kamiya and Kento Koyama, the heads of the young studio CLOVERS, regarding its formation and the cancellation of Scalebound.

Windows Central

Clover Beats Q2 Estimates, Stock Drops: Here Are The Details

Healthcare technology company Clover Health Investments Corp. (NASDAQ:CLOV) is trading lower after reporting second-quarter financial results after market close on Tuesday.

Benzinga

What's Going On With Clover Health Stock?

Clover Health Investments, Corp. (NASDAQ:CLOV) stock is trading 5% higher on Tuesday, adding to gains of more than 12% over the past week. Here’s a look at some key highlights.

Benzinga

Missed the Hims & Hers Rally? Clover Health Could Be Next

After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Louder

“People think we’re a pop band. But we never have been. We just had some huge success that hurt us a little”: how Huey Lewis & The News became America’s favourite good time rock’n’roll band

Huey Lewis & The News were the ultimate bar-room rockers made good – all it took was a little nudge from Mutt Lange and Michael J Fox

The Independent UK

4-H teams with Netflix's 'Spy Kids: Armageddon' to launch new learning platform Clover

The National 4-H Council is growing in a new direction – online – by launching its e-learning platform Clover with a collaboration with Netflix and its new movie “Spy Kids: Armageddon.”

StockNews.com

Clover Health Investments (CLOV): Buy, Hold or Sell End of June?

Clover Health (CLOV) has been subject to several lawsuits and federal investigations. Also, the company’s bottom line is in the red. However, CLOV is ramping up its efforts to accelerate its path to profitability. So, should you Buy, Hold or Sell the stock now? Read on to learn my views.

Belfast Live

The Clover Group buys Belfast bar the Eglantine Inn creating 30 new jobs and planning £500k refurbishment

The venue was first designed in 1988 by the same architects as the iconic Crown Bar

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Noted New Orleans social services group drops racist's name

A New Orleans social services nonprofit long known as the Kingsley House has ditched the name of a Victorian clergyman found to have held profoundly racist views

Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

RideApart

Clover Wants You To Stay Breezy With The Netstyle 2 Jacket

Italian gear and apparel maker Clover introduces the Netstyle 2 riding jacket for the 2022 season. This mesh jacket is meant to keep you cool this summer.

Bangkok Post

China's Clover says its Covid booster shot candidate lifts antibody against Omicron

BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody response against the Omicron coronavirus variant from levels seen after two primary shots.

Bangkok Post

Victoria's Secret to pay B285m settlement to laid-off Thai workers

Thai workers who were sacked last year from a factory supplying global lingerie brands including Victoria's Secret will receive 285.2 million baht, in what labour activists say is the biggest settlement of its kind in the global garment industry.

Benzinga

How Clover Mortgage Is Helping Metro Detroiters Save On Homeownership As Rates Begin To Climb

Through the pandemic, Americans went on a homebuying spree. Amidst trends accelerated by work-from-home and pandemic isolation, families, some of which were first-time home buyers, drew on an already limited supply.

Benzinga

Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action

Clover Biopharmaceuticals Ltd announced new promising data from a preclinical study on its bivalent vaccine candidate, which combines the trimeric spike antigens from the original SARS-CoV-2 strain and the omicron variant. Clover developed the SCB-2019 antigen, a stabilized trimeric form of the S-protein based on the original strain of the SARS-CoV-2 virus. It…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.